A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women
Objective: The aim of this study was to determine vasomotor symptom (VMS) prevalence, duration, and impact on quality of life in middle-aged women using a validated menopausal tool. Methods: The Menopause Rating Scale (MRS) and an itemized questionnaire containing personal sociodemographic data were...
- Autores:
-
Blumel, Juan E.
Chedraui, Peter
Baron, German
Belzares, Emma
Bencosme, Ascanio
Calle, , Andres
Danckers, Luis
Espinoza, Maria T.
Flores, Daniel
Gomez, Gustavo
Hernandez-Bueno, Jose A.
Izaguirre, Humberto
Leon-Leon, Patricia
Lima, Selva
Mezones-Holguin, Edward
Monterrosa-Castro, Álvaro
Mostajo, Desire
Navarro, Daysi
Ojeda, Eliana
Onatra, William
Royer, Monique
Soto, Edwin
Tserotas, Konstantinos
Vallejo, Soledad
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2011
- Institución:
- Universidad de Cartagena
- Repositorio:
- Repositorio Universidad de Cartagena
- Idioma:
- eng
- OAI Identifier:
- oai:repositorio.unicartagena.edu.co:11227/20185
- Acceso en línea:
- https://hdl.handle.net/11227/20185
- Palabra clave:
- 3. Ciencias Médicas y de la Salud
Vasomotor symptoms
Prevalence
Menopause Rating Scale
Menopause
Latin America.
ODS 3: Salud y bienestar. Garantizar una vida sana y promover el bienestar de todos a todas las edades
- Rights
- openAccess
- License
- https://creativecommons.org/licenses/by-nc/4.0/
| id |
UCART2_59285732257d722bd0d3e4145be31f21 |
|---|---|
| oai_identifier_str |
oai:repositorio.unicartagena.edu.co:11227/20185 |
| network_acronym_str |
UCART2 |
| network_name_str |
Repositorio Universidad de Cartagena |
| repository_id_str |
|
| dc.title.eng.fl_str_mv |
A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women |
| title |
A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women |
| spellingShingle |
A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women 3. Ciencias Médicas y de la Salud Vasomotor symptoms Prevalence Menopause Rating Scale Menopause Latin America. ODS 3: Salud y bienestar. Garantizar una vida sana y promover el bienestar de todos a todas las edades |
| title_short |
A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women |
| title_full |
A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women |
| title_fullStr |
A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women |
| title_full_unstemmed |
A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women |
| title_sort |
A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women |
| dc.creator.fl_str_mv |
Blumel, Juan E. Chedraui, Peter Baron, German Belzares, Emma Bencosme, Ascanio Calle, , Andres Danckers, Luis Espinoza, Maria T. Flores, Daniel Gomez, Gustavo Hernandez-Bueno, Jose A. Izaguirre, Humberto Leon-Leon, Patricia Lima, Selva Mezones-Holguin, Edward Monterrosa-Castro, Álvaro Mostajo, Desire Navarro, Daysi Ojeda, Eliana Onatra, William Royer, Monique Soto, Edwin Tserotas, Konstantinos Vallejo, Soledad |
| dc.contributor.author.none.fl_str_mv |
Blumel, Juan E. Chedraui, Peter Baron, German Belzares, Emma Bencosme, Ascanio Calle, , Andres Danckers, Luis Espinoza, Maria T. Flores, Daniel Gomez, Gustavo Hernandez-Bueno, Jose A. Izaguirre, Humberto Leon-Leon, Patricia Lima, Selva Mezones-Holguin, Edward Monterrosa-Castro, Álvaro Mostajo, Desire Navarro, Daysi Ojeda, Eliana Onatra, William Royer, Monique Soto, Edwin Tserotas, Konstantinos Vallejo, Soledad |
| dc.contributor.researchgroup.none.fl_str_mv |
Grupo de investigación Salud de la Mujer |
| dc.subject.ocde.none.fl_str_mv |
3. Ciencias Médicas y de la Salud |
| topic |
3. Ciencias Médicas y de la Salud Vasomotor symptoms Prevalence Menopause Rating Scale Menopause Latin America. ODS 3: Salud y bienestar. Garantizar una vida sana y promover el bienestar de todos a todas las edades |
| dc.subject.proposal.none.fl_str_mv |
Vasomotor symptoms Prevalence Menopause Rating Scale Menopause Latin America. |
| dc.subject.ods.none.fl_str_mv |
ODS 3: Salud y bienestar. Garantizar una vida sana y promover el bienestar de todos a todas las edades |
| description |
Objective: The aim of this study was to determine vasomotor symptom (VMS) prevalence, duration, and impact on quality of life in middle-aged women using a validated menopausal tool. Methods: The Menopause Rating Scale (MRS) and an itemized questionnaire containing personal sociodemographic data were used to examine 8,373 women aged 40 to 59 years from 22 healthcare centers in 12 Latin American countries. Results: Less than half (48.8%) of all women studied were postmenopausal, 14.7% used hormone therapy (HT), 54.5% presented VMS of any degree, and 9.6% presented severe/bothersome symptoms. The rate of VMS (any degree) significantly increased from one menopausal stage to the next. HT users presented more VMS (any degree) than did nonusers (58.6% vs 53.8%, P = 0.001). When surgical postmenopausal women were compared, nonYHT users displayed a higher prevalence of severe VMS (16.1% vs 9.0%, P = 0.0001). The presence of VMS of any degree was related to a more impaired quality of life (higher total MRS score; odds ratio, 4.7; 95% CI, 4.1-5.3). This effect was even higher among women presenting severe VMS. Logistic regression analysis determined that the presence of severe psychological/urogenital symptoms (MRS), lower educational level, natural perimenopausepostmenopause status, nulliparity, surgical menopause, and living at high altitude were significant risk factors for severe VMS. HT use was related to a lower risk. A second regression model determined that surgical menopause, intense psychological/urogenital symptoms, and a history of psychiatric consultation were factors related to severe VMS persisting into the late postmenopausal stage (5 or more years). Conclusions: In this Latin American middle-aged series, VMS prevalence was high, persisting into the late postmenopausal phase in a high rate and severely impairing quality of life. HT use was related to a lower risk of severe VMS. |
| publishDate |
2011 |
| dc.date.issued.none.fl_str_mv |
2011 |
| dc.date.accessioned.none.fl_str_mv |
2025-09-11T17:52:47Z |
| dc.date.available.none.fl_str_mv |
2025-09-11T17:52:47Z |
| dc.type.none.fl_str_mv |
Artículo de revista |
| dc.type.version.none.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.coarversion.none.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.coar.none.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
| dc.type.content.none.fl_str_mv |
Text |
| dc.type.driver.none.fl_str_mv |
info:eu-repo/semantics/article |
| format |
http://purl.org/coar/resource_type/c_2df8fbb1 |
| status_str |
publishedVersion |
| dc.identifier.issn.none.fl_str_mv |
1072 - 3714 |
| dc.identifier.uri.none.fl_str_mv |
https://hdl.handle.net/11227/20185 |
| dc.identifier.eissn.none.fl_str_mv |
1530 - 0374 |
| identifier_str_mv |
1072 - 3714 1530 - 0374 |
| url |
https://hdl.handle.net/11227/20185 |
| dc.language.iso.none.fl_str_mv |
eng |
| language |
eng |
| dc.relation.ispartofjournal.none.fl_str_mv |
Menopause: The Journal of The North American Menopause Society |
| dc.relation.citationendpage.none.fl_str_mv |
8 |
| dc.relation.citationissue.none.fl_str_mv |
7 |
| dc.relation.citationstartpage.none.fl_str_mv |
1 |
| dc.relation.citationvolume.none.fl_str_mv |
18 |
| dc.relation.references.none.fl_str_mv |
NIH State of the Science Conference. Statement on management of menopause related symptoms. NIH Consens State Sci Statements 2005; 22:1-38. Greene JG. Constructing a standard climacteric scale. Maturitas 1998; 29:25-31 MacLennan A, Lester S, Moore V. Oral oestrogen replacement therapy versus placebo for hot flushes. Cochrane Database Syst Rev 2001;(1): CD002978. Crandall CJ, Zheng Y, Crawford SL, et al. Presence of vasomotor symptoms is associated with lower bone mineral density: a longitudinal analysis. Menopause 2009;16:239-246. Thurston RC, Sutton-Tyrrell K, Everson-Rose SA, Hess R, Matthews KA. Hot flashes and subclinical cardiovascular disease: findings from the Study of Women’s Health Across the Nation Heart Study. Circulation 2008;118:1234-1240. Politi MC, Schleinitz MD, Col NF. Revisiting the duration of vasomotor symptoms of menopause: a meta-analysis. J Gen Intern Med 2008;23: 1507-1513. |
| dc.rights.uri.none.fl_str_mv |
https://creativecommons.org/licenses/by-nc/4.0/ |
| dc.rights.license.none.fl_str_mv |
Atribución-NoComercial 4.0 Internacional (CC BY-NC 4.0) |
| dc.rights.coar.none.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
| dc.rights.accessrights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc/4.0/ Atribución-NoComercial 4.0 Internacional (CC BY-NC 4.0) http://purl.org/coar/access_right/c_abf2 |
| eu_rights_str_mv |
openAccess |
| dc.format.mimetype.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Ovid Technologico (Woltersm Kluwer) |
| dc.publisher.place.none.fl_str_mv |
Estados Unidos |
| publisher.none.fl_str_mv |
Ovid Technologico (Woltersm Kluwer) |
| dc.source.none.fl_str_mv |
https://pubmed.ncbi.nlm.nih.gov/21407137/ |
| institution |
Universidad de Cartagena |
| bitstream.url.fl_str_mv |
https://repositorio.unicartagena.edu.co/bitstreams/5eb3a24d-a229-402f-9108-36c198db58ed/download https://repositorio.unicartagena.edu.co/bitstreams/0f1d1668-fb67-4b72-8d18-d0d71da6623a/download https://repositorio.unicartagena.edu.co/bitstreams/7951e6d6-783c-4754-a8d6-ae947139494c/download https://repositorio.unicartagena.edu.co/bitstreams/0629ab88-222a-4a19-a256-f89c45510fb0/download |
| bitstream.checksum.fl_str_mv |
70b93afbdc8062b04d3c9d7e0740e7b3 64eb6cdbc122cfe492fa78c8434a0f6b 260b704b22f974068b6ff7f6587cdd0e b0d55b735a97331c655e9861b1333de6 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Biblioteca Digital Universidad de Cartagena |
| repository.mail.fl_str_mv |
bdigital@metabiblioteca.com |
| _version_ |
1851053483374936064 |
| spelling |
Blumel, Juan E.Chedraui, PeterBaron, GermanBelzares, EmmaBencosme, AscanioCalle, , AndresDanckers, LuisEspinoza, Maria T.Flores, DanielGomez, GustavoHernandez-Bueno, Jose A.Izaguirre, HumbertoLeon-Leon, PatriciaLima, SelvaMezones-Holguin, EdwardMonterrosa-Castro, ÁlvaroMostajo, DesireNavarro, DaysiOjeda, ElianaOnatra, WilliamRoyer, MoniqueSoto, EdwinTserotas, KonstantinosVallejo, SoledadGrupo de investigación Salud de la Mujer2025-09-11T17:52:47Z2025-09-11T17:52:47Z20111072 - 3714https://hdl.handle.net/11227/201851530 - 0374Objective: The aim of this study was to determine vasomotor symptom (VMS) prevalence, duration, and impact on quality of life in middle-aged women using a validated menopausal tool. Methods: The Menopause Rating Scale (MRS) and an itemized questionnaire containing personal sociodemographic data were used to examine 8,373 women aged 40 to 59 years from 22 healthcare centers in 12 Latin American countries. Results: Less than half (48.8%) of all women studied were postmenopausal, 14.7% used hormone therapy (HT), 54.5% presented VMS of any degree, and 9.6% presented severe/bothersome symptoms. The rate of VMS (any degree) significantly increased from one menopausal stage to the next. HT users presented more VMS (any degree) than did nonusers (58.6% vs 53.8%, P = 0.001). When surgical postmenopausal women were compared, nonYHT users displayed a higher prevalence of severe VMS (16.1% vs 9.0%, P = 0.0001). The presence of VMS of any degree was related to a more impaired quality of life (higher total MRS score; odds ratio, 4.7; 95% CI, 4.1-5.3). This effect was even higher among women presenting severe VMS. Logistic regression analysis determined that the presence of severe psychological/urogenital symptoms (MRS), lower educational level, natural perimenopausepostmenopause status, nulliparity, surgical menopause, and living at high altitude were significant risk factors for severe VMS. HT use was related to a lower risk. A second regression model determined that surgical menopause, intense psychological/urogenital symptoms, and a history of psychiatric consultation were factors related to severe VMS persisting into the late postmenopausal stage (5 or more years). Conclusions: In this Latin American middle-aged series, VMS prevalence was high, persisting into the late postmenopausal phase in a high rate and severely impairing quality of life. HT use was related to a lower risk of severe VMS.application/pdfengOvid Technologico (Woltersm Kluwer)Estados UnidosMenopause: The Journal of The North American Menopause Society87118NIH State of the Science Conference. Statement on management of menopause related symptoms. NIH Consens State Sci Statements 2005; 22:1-38.Greene JG. Constructing a standard climacteric scale. Maturitas 1998; 29:25-31MacLennan A, Lester S, Moore V. Oral oestrogen replacement therapy versus placebo for hot flushes. Cochrane Database Syst Rev 2001;(1): CD002978.Crandall CJ, Zheng Y, Crawford SL, et al. Presence of vasomotor symptoms is associated with lower bone mineral density: a longitudinal analysis. Menopause 2009;16:239-246.Thurston RC, Sutton-Tyrrell K, Everson-Rose SA, Hess R, Matthews KA. Hot flashes and subclinical cardiovascular disease: findings from the Study of Women’s Health Across the Nation Heart Study. Circulation 2008;118:1234-1240.Politi MC, Schleinitz MD, Col NF. Revisiting the duration of vasomotor symptoms of menopause: a meta-analysis. J Gen Intern Med 2008;23: 1507-1513.https://creativecommons.org/licenses/by-nc/4.0/Atribución-NoComercial 4.0 Internacional (CC BY-NC 4.0)http://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccesshttps://pubmed.ncbi.nlm.nih.gov/21407137/A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged womenArtículo de revistainfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_2df8fbb1Textinfo:eu-repo/semantics/article3. Ciencias Médicas y de la SaludVasomotor symptomsPrevalenceMenopause Rating ScaleMenopauseLatin America.ODS 3: Salud y bienestar. Garantizar una vida sana y promover el bienestar de todos a todas las edadeshttps://www.grupodeinvestigacionsaluddelamujer.com/ORIGINAL12_BOCHORNOS LATINOAMERICA.pdf12_BOCHORNOS LATINOAMERICA.pdfapplication/pdf118005https://repositorio.unicartagena.edu.co/bitstreams/5eb3a24d-a229-402f-9108-36c198db58ed/download70b93afbdc8062b04d3c9d7e0740e7b3MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-81802https://repositorio.unicartagena.edu.co/bitstreams/0f1d1668-fb67-4b72-8d18-d0d71da6623a/download64eb6cdbc122cfe492fa78c8434a0f6bMD52TEXT12_BOCHORNOS LATINOAMERICA.pdf.txt12_BOCHORNOS LATINOAMERICA.pdf.txtExtracted texttext/plain48870https://repositorio.unicartagena.edu.co/bitstreams/7951e6d6-783c-4754-a8d6-ae947139494c/download260b704b22f974068b6ff7f6587cdd0eMD53THUMBNAIL12_BOCHORNOS LATINOAMERICA.pdf.jpg12_BOCHORNOS LATINOAMERICA.pdf.jpgGenerated Thumbnailimage/jpeg17044https://repositorio.unicartagena.edu.co/bitstreams/0629ab88-222a-4a19-a256-f89c45510fb0/downloadb0d55b735a97331c655e9861b1333de6MD5411227/20185oai:repositorio.unicartagena.edu.co:11227/201852025-09-12 05:02:55.814https://creativecommons.org/licenses/by-nc/4.0/open.accesshttps://repositorio.unicartagena.edu.coBiblioteca Digital Universidad de Cartagenabdigital@metabiblioteca.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 |
